CureSureMedico
Currency

Hepatitis B & C Treatment

Gastroenterology

payments

Starting from

$1,000

Up to $8,000 depending on centre

schedule

Typical duration

7–90 days

Including pre-operative work-up

medical_services

Procedures

3

Hold to see procedures

arrow_downwardlocal_hospital

Partner hospitals

0

Vetted for outcome data & accreditation

Overview

Access cutting-edge direct-acting antiviral (DAA) therapy for Hepatitis C with cure rates exceeding 95%, and specialist antiviral management for chronic Hepatitis B to suppress viral load and prevent cirrhosis. India and Turkey offer FDA-approved generic DAAs at dramatically lower costs, making a cure accessible for patients priced out of treatment at home.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Specialist hepatology consultation with full liver function panel and viral load testing
Liver fibrosis assessment (FibroScan or biopsy if indicated)
Complete course of prescribed antiviral medication with pharmacy coordination
Follow-up blood tests at 4 weeks and end-of-treatment to monitor response
Patient coordinator support for medication procurement and scheduling
Detailed treatment summary and home-physician handover documentation

Coordinated from

$1,000

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Global cost comparison — Hepatitis B & C Treatment

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

CountryAvg. cost
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Best value
$1,800
🇹🇷

Turkey

Istanbul

$5,000

Costs are indicative and reviewed quarterly. Request a personalised estimate for your specific case.

Frequently asked questions

In many countries, branded DAA regimens cost USD 15,000–80,000 for a full course and are only partially covered by insurance. India produces WHO-prequalified generic versions of the same FDA-approved drugs (sofosbuvir/velpatasvir, sofosbuvir/ledipasvir, etc.) at 1–3% of branded prices. A full 12-week curative course can cost as little as USD 800–1,500 in India. Patients from Africa, the Middle East, and parts of Asia who cannot access subsidized treatment at home travel to India specifically for this. Our coordinators verify the authenticity and regulatory approval of every medication dispensed at partner pharmacies.

No fees. No commitment.

Our guidance is completely free

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp